Fingerprint
Dive into the research topics of 'Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically